IRulya Therapeutics grants CFO John Militello 80,000 restricted stock units
IRLA•IRulya Therapeutics granted CFO John Militello 80,000 shares of common stock on Nov. 9, 2026.
1. Stock grant
IRulya Therapeutics granted Chief Financial Officer John Militello 80,000 shares of common stock on Nov. 9, 2026.
